Nevertheless, our present data, together with previous reports [7,32] raise the possibility that, in vivo, CCR5 usage ability, required for an efficient in vivo infection, could be acquired, from an initial population of CCR5/CXCR4-independent viruses, in addition or in alternative to the initial receptors used. The gene discussed is CXCR4; the disease is infection.